Cardiac positron emission tomography/computed tomography imaging of the renin-angiotensin system in humans holds promise for image-guided approach to heart failure therapy

Journal of the American College of Cardiology

Volumn 60, Issue 24, 2012, Pages 2535-2538

  Schindler, Thomas H ^a   Dilsizian, Vasken ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

angiotensin receptor; molecular imaging; positron emission tomography

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUOROBENZOYL LISINOPRIL F 18; FLUOROCAPTOPRIL F 18; IODOTYROSYL LISINOPRIL I 125; KR 31173; KR 31173 C 11; L 159884; L 159884 C 11; LOSARTAN TC 99M; N [[4' [(2 ETHYL 5,7 DIMETHYL 3H IMIDAZO[4,5 B]PYRIDIN 3 YL)METHYL] 2 BIPHENYLYL]SULFONYL]BENZAMIDE; N [[4' [(2 ETHYL 5,7 DIMETHYL 3H IMIDAZO[4,5 B]PYRIDIN 3 YL)METHYL] 2 BIPHENYLYL]SULFONYL]BENZAMIDE C 11; RADIOPHARMACEUTICAL AGENT; RENIN INHIBITOR; UNCLASSIFIED DRUG; ZOFENOPRILAT C 11;

BINDING AFFINITY; CARDIOMYOPATHY; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED EMISSION TOMOGRAPHY; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; DRUG PROTEIN BINDING; ELDERLY CARE; ETHNIC DIFFERENCE; GENETIC PREDISPOSITION; HEART FAILURE; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; IMMUNOHISTOCHEMISTRY; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MOLECULAR IMAGING; MORBIDITY; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY OF LIFE; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; TISSUE DISTRIBUTION; TREATMENT RESPONSE; VALVULAR HEART DISEASE;

EID: 84871274776     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.09.022     Document Type: Editorial

References (19)

1. S.A. Hunt, W.T. Abraham, M.H. Chin 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 53 2009 e1 e90
2. A.T. Owens, M. Jessup The year in heart failure J Am Coll Cardiol 60 2012 359 368
3. J. Shirani, V. Dilsizian Imaging left ventricular remodeling: targeting the neurohumoral axis Nat Clin Pract Cardiovasc Med 5 Suppl 2 2008 S57 S62
4. E. Braunwald, M.J. Domanski, S.E. Fowler Angiotensin-converting-enzyme inhibition in stable coronary artery disease N Engl J Med 351 2004 2058 2068
5. C.W. Yancy, D.C. Lee Personalized medicine in heart failure: are we there yet? J Am Coll Cardiol Img 5 2012 419 421
6. V.J. Dzau Implications of local angiotensin production in cardiovascular physiology and pharmacology Am J Cardiol 59 1987 59A 65A
7. K. Fukushima, P.E. Bravo, T. Higuchi Molecular hybrid positron emission tomography/computed tomography imaging of cardiac angiotensin II type 1 receptors J Am Coll Cardiol 60 2012 2527 2534
8. J.W. Verjans, D. Lovhaug, N. Narula Noninvasive imaging of angiotensin receptors after myocardial infarction J Am Coll Cardiol Img 1 2008 354 362
9. M.A. Pfeffer, E. Braunwald, L.A. Moye SAVE Investigators Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction Results of the survival and ventricular enlargement trial N Engl J Med 327 1992 669 677
10. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
11. The CONSENSUS Trial Study Group Effects of enalapril on mortality in severe congestive heart failure Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) N Engl J Med 316 1987 1429 1435
12. V. Dilsizian, W.C. Eckelman, M.L. Loredo, E.M. Jagoda, J. Shirani Evidence for tissue angiotensin-converting enzyme in explanted hearts of ischemic cardiomyopathy using targeted radiotracer technique J Nucl Med 48 2007 182 187
13. Y.H.C. Lee, D.O. Kiesewetter, L. Lang Synthesis of 4-[18F] fluorobenzoyllisinopril: a radioligand for angiotensin converting enzyme (ACE) imaging with positron emission tomography J Labelled Cpd Radiopharm 44 2001 S268 S270
14. V. Dilsizian, T.K. Zynda, A. Petrov Molecular imaging of human ACE-1 expression in transgenic rats J Am Coll Cardiol Img 5 2012 409 418
15. F.J. Femia, K.P. Maresca, S.M. Hillier Synthesis and evaluation of a series of 99mTc(CO)3+ lisinopril complexes for in vivo imaging of angiotensin-converting enzyme expression J Nucl Med 49 2008 970 977
16. X.L. Tian, Y.M. Pinto, O. Costerousse Over-expression of angiotensin converting enzyme-1 augments cardiac hypertrophy in transgenic rats Hum Mol Genet 13 2004 1441 1450
17. W.C. Eckelman Design criteria for targeted molecules: muscarinic cholinergic systems biology M.J. Welch, W.C. Eckelman, Targeted Molecular Imaging 2012 Taylor & Francis Group Boca Raton, FL 201 215
18. L.C. van Vark, M. Bertrand, K.M. Akkerhuis Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158 998 patients Eur Heart J 33 2012 2088 2097
19. D.R. Hwang, W.C. Eckelman, C.J. Mathias, E.W. Petrillo Jr., J. Lloyd, M.J. Welch Positron-labeled angiotensin-converting enzyme (ACE) inhibitor: fluorine-18-fluorocaptopril Probing the ACE activity in vivo by positron emission tomography J Nucl Med 32 1991 1730 1737